Medical Xpress news
Medical Xpress / Glut1 protein may be a potential therapeutic target for kidney disease
Targeting and disabling a certain protein essential to transporting glucose properly through cells (Glucose Transporter 1, or Glut1) could be a new way to fight kidney disease, according to a study led by Partha Biswas, DVM, ...
Medical Xpress / Debates about bullying need to look beyond online safety, say researchers
New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London has found that only 2% of young people who experience cyberbullying by age 18 report exclusively being abused online.
Medical Xpress / AI models can rival humans in anonymizing patient information from electronic health records
Researchers from the University of Oxford have benchmarked artificial intelligence (AI) tools capable of automatically removing personal information from patient electronic health records (EHRs) in a key step toward enabling ...
Medical Xpress / Contactless pulse measurement falters at high heart rates, finds study
Researchers at Bielefeld University have analyzed how reliably AI methods can detect pulse rates from simple video recordings. The technique, known as rPPG—remote photoplethysmography, an optical form of contactless pulse ...
Medical Xpress / Parenting styles play a key role in shaping teen mental health
Mental health is a global crisis, with more than 1 billion people affected by mental health conditions, according to the World Health Organization (WHO). Young people are particularly affected, with suicide as the third leading ...
Medical Xpress / Ozempic can reduce metabolic risks in schizophrenia patients, multicenter study finds
Semaglutide medications like Ozempic and Wegovy can help lower the risk of heart and metabolic diseases in people with schizophrenia spectrum disorders, according to a study published in JAMA Psychiatry.
Medical Xpress / Reversing treatment resistance in prostate cancer: Study solves longstanding puzzle in tumor biology
Scientists at the Herbert Irving Comprehensive Cancer Center (HICCC) have discovered a key mechanism that makes prostate cancer cells resistant to the latest drugs used to treat them. Their findings, reported in the current ...
Medical Xpress / Rethinking long-term allergy treatments: Experimental vaccine protects against anaphylaxis in mice
Researchers led by the Institut Pasteur, Université Paris, have developed a vaccine that elicits anti-Immunoglobulin E antibodies in humanized mice, protects against Immunoglobulin E-mediated anaphylaxis, and shows no detectable ...
Medical Xpress / Fish oil supplement halves serious cardiovascular events in patients on dialysis, clinical trial finds
A daily fish oil supplement has been shown to significantly reduce serious cardiovascular events in people receiving dialysis for kidney failure. The findings come from a major international clinical trial co-led in Australia ...
Medical Xpress / Astrocyte diversity across space and time charted in new atlas
When it comes to brain function, neurons get a lot of the glory. But healthy brains depend on the cooperation of many kinds of cells. The most abundant of the brain's non-neuronal cells are astrocytes, star-shaped cells with ...
Medical Xpress / 'Ready-made' T-cell gene therapy tackles 'incurable' T-cell leukemia
A new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond Street Hospital (GOSH), has shown promising results in helping children and adults fight a rare ...
Medical Xpress / Health impacts related to 'forever chemicals' linked to billions in economic losses
The negative health impacts from contamination by so-called forever chemicals in drinking water costs the contiguous U.S. at least $8 billion a year in social costs, a University of Arizona-led study has found.
